Unasyn Injection, Powder, For Solution
Product Images NDC 0049-0024

7 FDA label images from Roerig · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Unasyn (NDC 0049-0024). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Roerig, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Unasyn Bulk 01)

Chemical Structure (Unasyn Bulk 01)
Chemical structure of the active ingredient in Unasyn, depicting the molecular framework including a beta-lactam ring, a thiazolidine ring, an amino group, and a carboxylate sodium salt group.*
FDA Label Image

Chemical Structure (Unasyn Bulk 02)

Chemical Structure (Unasyn Bulk 02)
Chemical structure diagram of the active ingredient, corresponding to Unasyn. The diagram shows key molecular components including a beta-lactam ring, sodium carboxylate group, methyl groups, and a sulfone moiety, consistent with the known chemical structure of the drug's active compound.*
FDA Label Image

Logo (Unasyn Bulk 03)

FDA Label Image

Principal Display Panel (15 g Bulk Vial Label)

Principal Display Panel (15 g Bulk Vial Label)
Unasyn 15 g sterile injection label by Roerig, a division of Pfizer Inc. The label shows ampicillin sodium and sulbactam sodium injectable powder for intravenous use. Concentrations are 100 mg/mL ampicillin and 50 mg/mL sulbactam after reconstitution with sterile water or 0.9% sodium chloride. It is a pharmacy bulk package not for direct infusion, requiring dilution and aseptic preparation.*
FDA Label Image

Principal Display Panel (15 g Bulk Carton)

Principal Display Panel (15 g Bulk Carton)
Unasyn 15 g sterile pharmacy bulk package for intravenous use, containing ampicillin sodium and sulbactam sodium. The label states it is not for direct infusion and provides dilution instructions to yield 100 mg/mL ampicillin and 50 mg/mL sulbactam solutions. Distributed by Roerig, a division of Pfizer Inc.*
FDA Label Image

Principal Display Panel (15 g Bulk Vial ampicillin and sulbactam)

Principal Display Panel (15 g Bulk Vial ampicillin and sulbactam)
Unasyn 15 g sterile injection vial label with active ingredients ampicillin and sulbactam for intravenous use. The label includes concentration information (100 mg/mL ampicillin and 50 mg/mL sulbactam), reconstitution instructions, storage conditions at or below 86°F (30°C), and a warning that the reconstituted bulk solution is not for direct infusion. Distributed by Roerig, a division of Pfizer Inc., New York, NY.*
FDA Label Image

Principal Display Panel (15 g Bulk Carton ampicillin and sulbactam)

Principal Display Panel (15 g Bulk Carton ampicillin and sulbactam)
Unasyn 15 g (ampicillin and sulbactam) for injection, USP packaging label from Roerig (Pfizer). The label states it is a sterile vial for intravenous use and a pharmacy bulk package not for direct infusion. It includes dosing preparation instructions, storage conditions, and barcode information. The label displays the strength 15 g prominently on a white and green background.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.